Advertisement
Advertisement
CNTA
Centessa Pharmaceuticals plc - ADR
39.77
USDSponsored
+0.08
+0.20%
Jun 11, 16:00 UTC -4
Closed
After-Market
39.77
-0.01
-0.01%
CNTA Earnings Reports
Positive Surprise Ratio
CNTA beat 11 of 20 last estimates.
55%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.43
Implied change from Q1 26 (Revenue/ EPS)
--
/-17.31%
Implied change from Q2 25 (Revenue/ EPS)
--
/+13.16%
Centessa Pharmaceuticals plc - ADR earnings per share and revenue
On May 05, 2026, CNTA reported earnings of -0.52 USD per share (EPS) for Q1 26, missing the estimate of -0.40 USD, resulting in a -28.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.18% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.43 USD, with revenue projected to reach -- USD, implying an decrease of -17.31% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Centessa Pharmaceuticals plc - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Centessa Pharmaceuticals plc - ADR reported EPS of -$0.52, missing estimates by -28.65%, and revenue of $0.00, 0% as expectations.
How did the market react to Centessa Pharmaceuticals plc - ADR's Q1 2026 earnings?
The stock price moved down -0.18%, changed from $39.67 before the earnings release to $39.60 the day after.
When is Centessa Pharmaceuticals plc - ADR expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Centessa Pharmaceuticals plc - ADR's next earnings report?
Based on 8
analysts, Centessa Pharmaceuticals plc - ADR is expected to report EPS of -$0.43 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement